Skip Nav Destination
1-20 of 21
Keywords: Heart failureClose
Yuta Suzuki, Hidehiro Kaneko, Akira Okada, Katsuhito Fujiu, Nobuaki Michihata, Taisuke Jo, Norifumi Takeda, Hiroyuki Morita, Kentaro Kamiya, Atsuhiko Matsunaga, Junya Ako, Koichi Node, Masaomi Nangaku, Hideo Yasunaga, Issei Komuro
Am J Nephrol (2022) 53 (10): 753–760.
Published Online: 31 January 2023
... with the risk for heart failure (HF) and other cardiovascular disease (CVD) events in patients with prior history of breast, colorectal, or stomach cancer using a nationwide population-based database. Methods: We conducted this retrospective observation study using the JMDC Claims Database and analyzed 55,191...
Alexander B. Sellier, Sarah Seiler-Mußler, Insa E. Emrich, Michael Böhm, Danilo Fliser, Adam M. Zawada, Gunnar H. Heine
Am J Nephrol (2021) 52 (10-11): 808–816.
Published Online: 21 October 2021
... kidney disease Heart failure Left-ventricular hypertrophy Gene polymorphism Left-ventricular hypertrophy (LVH) is a strong independent predictor of cardiovascular mortality in chronic kidney disease (CKD) patients . Since the causative pathophysiological pathways that link reduced renal...
Am J Nephrol (2020) 51 (7): 511–519.
Published Online: 13 July 2020
... kidney function. The present randomized controlled trial examines the effect of prophylactic AV fistula closure on high-output heart failure. Methods: Twenty-eight kidney transplant patients with stable graft function, absence of pre-existing severe cardiac failure, and brachial arterial flow rate...
David Z.I. Cherney, Enrico Repetto, David C. Wheeler, Suzanne V. Arnold, Sharon MacLachlan, Philip R. Hunt, Hungta Chen, Jiten Vora, Mikhail Kosiborod
Am J Nephrol (2020) 51 (1): 74–82.
Published Online: 06 December 2019
...), heart failure (HF), and all-cause mortality (ACM) in type 2 diabetes mellitus (T2DM) patients and its importance relative to the presence of other cardio-renal-metabolic (CaReMe) comorbidities. Methods: Patients (≥40 years) were identified at the time of T2DM diagnosis from US (Humedica/Optum) and UK...
Insa E. Emrich, Vincent Brandenburg, Alexander B. Sellier, Johanna Schauerte, Johanna Wiedenroth, Kathrin Untersteller, Claudia S. Lennartz, Sarah Seiler-Mussler, Stefan Wagenpfeil, Danilo Fliser, Gunnar H. Heine
Am J Nephrol (2019) 49 (3): 203–211.
Published Online: 26 February 2019
... rather than for recently discovered non-CKD-MBD regulators, among which iron deficiency and heart failure are of particular importance. Moreover, they used c-terminal FGF23 (cFGF23) assays rather than more specific intact FGF23 (iFGF23) assays. Methods: The CARE FOR HOMe study analyzed plasma ferritin...
Terumasa Hayashi, Keiko Yasuda, Tomonori Kimura, Koichi Sasaki, Karin Shimada, Nobuhiro Hashimoto, Yoshitaka Isaka
Am J Nephrol (2018) 48 (3): 205–213.
Published Online: 07 September 2018
...Terumasa Hayashi; Keiko Yasuda; Tomonori Kimura; Koichi Sasaki; Karin Shimada; Nobuhiro Hashimoto; Yoshitaka Isaka Background: It is unclear whether asymptomatic elevation of brain natriuretic peptide (BNP) is associated with cardiovascular events (CVEs) or heart failure (HF) in predialysis chronic...
Laurent Bitker, Florence Sens, Cécile Payet, Ségolène Turquier, Antoine Duclos, Vincent Cottin, Laurent Juillard
Am J Nephrol (2018) 47 (2): 134–143.
Published Online: 22 February 2018
...Laurent Bitker; Florence Sens; Cécile Payet; Ségolène Turquier; Antoine Duclos; Vincent Cottin; Laurent Juillard Background: Pulmonary arterial hypertension (PAH) may lead to right heart failure and subsequently alter glomerular filtration rates (GFR). Chronic kidney disease (CKD, GFR <60 mL/min...
Allan J. Collins, Bertram Pitt, Nancy Reaven, Susan Funk, Karen McGaughey, Daniel Wilson, David A. Bushinsky
Am J Nephrol (2017) 46 (3): 213–221.
Published Online: 02 September 2017
...Allan J. Collins; Bertram Pitt; Nancy Reaven; Susan Funk; Karen McGaughey; Daniel Wilson; David A. Bushinsky Background: The relationship between serum potassium, mortality, and conditions commonly associated with dyskalemias, such as heart failure (HF), chronic kidney disease (CKD...
Jessica B. Kendrick, Leila Zelnick, Michel B. Chonchol, David Siscovick, Andrew N. Hoofnagle, Joachim H. Ix, Mark Sarnak, Michael G. Shlipak, Bryan Kestenbaum, Ian H. de Boer
Am J Nephrol (2017) 45 (2): 118–126.
Published Online: 10 December 2016
..., and stroke death), and (3) incident heart failure. Results: During a median (interquartile range) follow-up of 8.5 (7.7-8.6) years, 331 (5.3%) participants had an incident CVE and 174 (2.8%) developed incident heart failure. We stratified analyses by use of diuretics because we observed a significant...
Stefan Bogdan, Eyal Nof, Alon Eisen, Ron Sela, Shimon Rosenheck, Nahum Freedberg, Michael Geist, Shlomit Ben-Zvi, Moti Haim, Michael Glikson, Ilan Goldenberg, Mahmoud Suleiman, on behalf of the Israeli working group of pacing and electrophysiology of the Israeli Heart Society
Am J Nephrol (2015) 42 (4): 295–304.
Published Online: 31 October 2015
... dysfunction is associated with increased mortality in heart failure (HF) patients. However, there are limited data regarding clinical and arrhythmic outcomes associated with implantable cardioverter defibrillator (ICD) therapy in this population. Methods: We evaluated outcomes associated with the severity...
Luis M. Ruilope, Rajiv Agarwal, Juliana C. Chan, Mark E. Cooper, Ron T. Gansevoort, Hermann Haller, Giuseppe Remuzzi, Peter Rossing, Roland E. Schmieder, Christina Nowack, Anna C. Ferreira, Alexander Pieper, Nina Kimmeskamp-Kirschbaum, George L. Bakris
Am J Nephrol (2015) 40 (6): 572–581.
Published Online: 10 January 2015
... albuminuria in patients having heart failure with reduced ejection fraction and mild-to-moderate (stage 2-3) chronic kidney disease. The MinerAlocorticoid Receptor Antagonist Tolerability Study-Diabetic Nephropathy (ARTS-DN; NCT01874431) is a multicenter, randomized, double-blind, placebo-controlled, parallel...
Mahboob Rahman, Dawei Xie, Harold I. Feldman, Alan S. Go, Jiang He, John W. Kusek, James Lash, Edgar R. Miller III, Akinlolu Ojo, Qiang Pan, Stephen L. Seliger, Susan Steigerwalt, Ray R. Townsend, for the CRIC Study Investigators
Am J Nephrol (2014) 40 (5): 399–407.
Published Online: 11 November 2014
... enrolled in the chronic renal insufficiency cohort (CRIC) study between June 2003 and June 2008. Prevalent cardiovascular disease (myocardial infarction/revascularization, heart failure, stroke, and peripheral vascular disease) was determined by self-report at baseline. The primary outcome was a composite...
Claudia Torino, Francesco Mattace-Raso, Jan L.C.M. van Saase, Graziella D'Arrigo, Rocco Tripepi, Giovanni Luigi Tripepi, Maurizio Postorino, Francesca Mallamaci, Carmine Zoccali, on behalf of the PROGREDIRE Working Group
Am J Nephrol (2014) 39 (6): 536–542.
Published Online: 12 June 2014
...), associates with all-cause and cardiovascular (CV) mortality in high-risk conditions such as chronic heart failure (HF). Because SDB and HF are exceedingly frequent in end-stage kidney disease (ESKD), we hypothesized that SDB as detected by snoring may impact upon the relationship between chronic HF and all...
Melanie P. Chin, Scott A. Reisman, George L. Bakris, Megan O'Grady, Peter G. Linde, Peter A. McCullough, David Packham, Nosratola D. Vaziri, Keith W. Ward, David G. Warnock, Colin J. Meyer
Am J Nephrol (2014) 39 (6): 499–508.
Published Online: 03 June 2014
... triterpenoid compound, was evaluated in a phase 3 trial (BEACON) in patients with type 2 diabetes mellitus (T2DM) and stage 4 chronic kidney disease (CKD). The trial was terminated because of an increase in heart failure events in the bardoxolone methyl group, many of which appeared related to fluid retention...
Nadezda Gut, Grzegorz Piecha, Firas Aldebssi, Sebastian Schaefer, Raffi Bekeredjian, Peter Schirmacher, Eberhard Ritz, Marie-Luise Gross-Weissmann
Am J Nephrol (2013) 38 (2): 124–135.
Published Online: 30 July 2013
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Erythropoietin ACE inhibitor Heart failure Hypertension Oxidative stress Chronic kidney disease (CKD...
C. Barrett Bowling, Margaret A. Feller, Marjan Mujib, Pushkar P. Pawar, Yan Zhang, O. James Ekundayo, Inmaculada B. Aban, Thomas E. Love, Paul W. Sanders, Stefan D. Anker, Gregg C. Fonarow, Ali Ahmed
Am J Nephrol (2011) 34 (2): 135–141.
Published Online: 04 July 2011
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Chronic kidney disease Heart failure National Institutes of Health (NIH) 10.13039/100000002 Elevated serum creatinine...
Peter A. McCullough, Barry A. Franklin, Eric Leifer, Gregg C. Fonarow, for the HF-ACTION Investigators
Am J Nephrol (2010) 32 (3): 226–233.
Published Online: 22 July 2010
...Peter A. McCullough; Barry A. Franklin; Eric Leifer; Gregg C. Fonarow; for the HF-ACTION Investigators Background: Decreased renal function has been consistently associated with increased mortality among patients with systolic heart failure. The relationship between estimated glomerular filtration...
Am J Nephrol (1991) 11 (6): 441–446.
Published Online: 28 October 2008
...Johannes Hensen; William T. Abraham; Jacques A. Dürr; Robert W. Schrier In patients with congestive heart failure (CHF), the role of aldosterone in the abnormal sodium (Na + ) retention and the determinants of plasma aldosterone (PA) including plasma atrial natriuretic factor (hANF), plasma renin...
Am J Nephrol (1983) 3 (5): 272–275.
Published Online: 22 October 2008
...Ronald Albright; Jeffrey Brensilver; Stanley Cortell To clarify the association between proteinuria and congestive heart failure (CHF), 24-hour urinary protein determinations were obtained from 27 patients with objectively documented CHF, before and after therapy of the CHF. The results demonstrate...
Am J Nephrol (2007) 27 (6): 649–660.
Published Online: 27 September 2007
...Alexander Sirker; Min Zhang; Colin Murdoch; Ajay M. Shah Cardiac remodelling occurs in response to stress, such as chronic hypertension or myocardial infarction, and forms the substrate for subsequent development of heart failure. Key pathophysiological features include ventricular hypertrophy...